Michael, M, Wieske, L, Allen, J, Lunn, M, Doppler, K, Tan, CY, Koike, H, Markvardsen, L, Kapoor, M, Hsieh, ST, Nobie-Orazio, E, Jacobs, B, Rajabally, Y, Basta, I, Ripellino, P, Querol, L, Eftimov, F. TREATMENT RESPONSE AND REFRACTORINESS IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (INCBASE). JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Hamadeh, T, van de Mortel, J, Van Doormaal, P, Cornblath, D, Vrancken, AFJE, Faber, C, Goedee, S, Minnema, M, Thomas, S, Khoshnoodi, M, Lunn, M, Keddie, S, Carr, A, D'Sa, S, Mair, D, Querol, L, Pascual-Goñi, E, Illa, CT, Harbo, T, Orazio, EN, Cutellè, C, Bianco, M, Svahn, J, Merle, H, Karlin, L, Echaniz-Laguna, A, Cauquil, C, Labeyrie, C, Peric, S, Basta, I, Palibrk, A, Stinoc, A, Briani, C, Salvalaggio, A, Marasca, M, Van den Bergh, P, Dubuisson, N, Marques, W Jr, Nascimento, O, Elsheikh, B, Doughty, C, Attarian, S, Delmont, E, Rausch, HW, Schirmer, L, Notermans, NC, Merkies, ISJ. RASCH-BUILT ATAXIA RATING SALE FOR IGM-ASSOCIATED POLYNEUROPATHY WITH AND WITHOUT ANTI-MAG ANTIBODIES (IGM-PNP RB-ARS). JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Doneddu, P, Asselta, R, Manganelli, F, Cocito, D, Inghilleri, M, Ricciardi, D, Cavaletti, G, Di Stefano, V, Filosto, M, Carta, A, Vegezzi, E, Matà, S, Habetswallner, F, Farotti, L, Luigetti, M, Ruiu, E, Mataluni, G, Falzone, Y, Carpo, M, Leonardi, L, Gentile, L, Ripellino, P, Peric, S, Basta, I, Querol, L, Jacobs, B, Eftimov, F, Orazio, EN. DISSECTING THE GENETIC ARCHITECTURE OF CIDP. STUDY PROTOCOL FOR AN INTERNATIONAL COLLABORATIVE GENOME-WIDE ASSOCIATION STUDY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).

Allen, J, Van Doorn, PA, Basta, I, Dysgaard, T, Eggers, C, Guptill, J, Gwathmey, K, Hewamadduma, C, Hofman, E, Hussain, Y, Kuwabara, S, Le Masson, G, Leypoldt, F, Lin, J, Lipowska, M, Lowe, M, Pinter, GL, Querol, L, Simu, MA, Chang, T, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA. EFFICACY AND SAFETY OF SUBCUTANEOUS (SC) EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).